323 related articles for article (PubMed ID: 28036274)
21. Bioinformatics analysis of aggressive behavior of breast cancer via an integrated gene regulatory network.
Yang X; Jia M; Li Z; Lu S; Qi X; Zhao B; Wang X; Rong Y; Shi J; Zhang Z; Xu W; Gao Y; Zhang S; Yu G
J Cancer Res Ther; 2014; 10(4):1013-8. PubMed ID: 25579546
[TBL] [Abstract][Full Text] [Related]
22. Gene expression signature of estrogen receptor alpha status in breast cancer.
Abba MC; Hu Y; Sun H; Drake JA; Gaddis S; Baggerly K; Sahin A; Aldaz CM
BMC Genomics; 2005 Mar; 6():37. PubMed ID: 15762987
[TBL] [Abstract][Full Text] [Related]
23. Integrated bioinformatics analysis reveals key candidate genes and pathways in breast cancer.
Wang Y; Zhang Y; Huang Q; Li C
Mol Med Rep; 2018 Jun; 17(6):8091-8100. PubMed ID: 29693125
[TBL] [Abstract][Full Text] [Related]
24. High-efficient Screening Method for Identification of Key Genes in Breast Cancer Through Microarray and Bioinformatics.
Liu Z; Liang G; Tan L; Su AN; Jiang W; Gong C
Anticancer Res; 2017 Aug; 37(8):4329-4335. PubMed ID: 28739725
[TBL] [Abstract][Full Text] [Related]
25. A novel framework for inferring condition-specific TF and miRNA co-regulation of protein-protein interactions.
Zhang J; Le TD; Liu L; He J; Li J
Gene; 2016 Feb; 577(1):55-64. PubMed ID: 26611531
[TBL] [Abstract][Full Text] [Related]
26. Application of a co‑expression network for the analysis of aggressive and non‑aggressive breast cancer cell lines to predict the clinical outcome of patients.
Guo L; Zhang K; Bing Z
Mol Med Rep; 2017 Dec; 16(6):7967-7978. PubMed ID: 28944917
[TBL] [Abstract][Full Text] [Related]
27. An integration of complementary strategies for gene-expression analysis to reveal novel therapeutic opportunities for breast cancer.
Bild AH; Parker JS; Gustafson AM; Acharya CR; Hoadley KA; Anders C; Marcom PK; Carey LA; Potti A; Nevins JR; Perou CM
Breast Cancer Res; 2009; 11(4):R55. PubMed ID: 19638211
[TBL] [Abstract][Full Text] [Related]
28. Analysis of the microarray gene expression for breast cancer progression after the application modified logistic regression.
Morais-Rodrigues F; Silv Erio-Machado R; Kato RB; Rodrigues DLN; Valdez-Baez J; Fonseca V; San EJ; Gomes LGR; Dos Santos RG; Vinicius Canário Viana M; da Cruz Ferraz Dutra J; Teixeira Dornelles Parise M; Parise D; Campos FF; de Souza SJ; Ortega JM; Barh D; Ghosh P; Azevedo VAC; Dos Santos MA
Gene; 2020 Feb; 726():144168. PubMed ID: 31759986
[TBL] [Abstract][Full Text] [Related]
29. Pan-organ transcriptome variation across 21 cancer types.
Hu W; Yang Y; Li X; Zheng S
Oncotarget; 2017 Jan; 8(4):6809-6818. PubMed ID: 28036280
[TBL] [Abstract][Full Text] [Related]
30. Identification of transcriptional factors and key genes in primary osteoporosis by DNA microarray.
Xie W; Ji L; Zhao T; Gao P
Med Sci Monit; 2015 May; 21():1333-44. PubMed ID: 25957414
[TBL] [Abstract][Full Text] [Related]
31. Characterizing disease states from topological properties of transcriptional regulatory networks.
Tuck DP; Kluger HM; Kluger Y
BMC Bioinformatics; 2006 May; 7():236. PubMed ID: 16670008
[TBL] [Abstract][Full Text] [Related]
32. Correlating transcriptional networks with pathological complete response following neoadjuvant chemotherapy for breast cancer.
Liu R; Lv QL; Yu J; Hu L; Zhang LH; Cheng Y; Zhou HH
Breast Cancer Res Treat; 2015 Jun; 151(3):607-18. PubMed ID: 25981901
[TBL] [Abstract][Full Text] [Related]
33. Bioinformatics analysis of gene expression data for the identification of critical genes in breast invasive carcinoma.
Li Y; Wang Y
Mol Med Rep; 2017 Dec; 16(6):8657-8664. PubMed ID: 28990063
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive analysis of the GATA transcription factor gene family in breast carcinoma using gene microarrays, online databases and integrated bioinformatics.
Yu S; Jiang X; Li J; Li C; Guo M; Ye F; Zhang M; Jiao Y; Guo B
Sci Rep; 2019 Mar; 9(1):4467. PubMed ID: 30872657
[TBL] [Abstract][Full Text] [Related]
35. Linking signaling pathways to transcriptional programs in breast cancer.
Osmanbeyoglu HU; Pelossof R; Bromberg JF; Leslie CS
Genome Res; 2014 Nov; 24(11):1869-80. PubMed ID: 25183703
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive analysis of the value of RAB family genes in prognosis of breast invasive carcinoma.
Lin S; Cao C; Meng Y; Wu P; Gao P; Zhi W; Peng T; Wu P; Gui L
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32432324
[TBL] [Abstract][Full Text] [Related]
37. Bioinformatic analysis reveals the key pathways and genes in early-onset breast cancer.
Cui C; Li L; Zhen J
Med Oncol; 2018 Apr; 35(5):67. PubMed ID: 29644522
[TBL] [Abstract][Full Text] [Related]
38. CancerLivER: a database of liver cancer gene expression resources and biomarkers.
Kaur H; Bhalla S; Kaur D; Raghava GP
Database (Oxford); 2020 Jan; 2020():. PubMed ID: 32147717
[TBL] [Abstract][Full Text] [Related]
39. Systems biology analysis reveals NFAT5 as a novel biomarker and master regulator of inflammatory breast cancer.
Remo A; Simeone I; Pancione M; Parcesepe P; Finetti P; Cerulo L; Bensmail H; Birnbaum D; Van Laere SJ; Colantuoni V; Bonetti F; Bertucci F; Manfrin E; Ceccarelli M
J Transl Med; 2015 May; 13():138. PubMed ID: 25928084
[TBL] [Abstract][Full Text] [Related]
40. Gene-set activity toolbox (GAT): A platform for microarray-based cancer diagnosis using an integrative gene-set analysis approach.
Engchuan W; Meechai A; Tongsima S; Doungpan N; Chan JH
J Bioinform Comput Biol; 2016 Aug; 14(4):1650015. PubMed ID: 27102089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
